MFY-28546-56080
4 vaccinations
1 coded response
41 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 452 / OH
- Registered
- 2021-04-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
MNJ-28394-22801
Child or adolescent in my care · Female · 2022-07-01
Timeline
-
2021-04-11
Dose 1 — Pfizer-BioNTech
-
2021-04-22
Registered in v-safe
- 2021-04-22
- 2021-04-25
-
2021-05-02
Dose 2 — Pfizer-BioNTech
- 2021-05-02
-
2021-05-03
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-05-04
- 2021-05-05
- 2021-05-06
- 2021-05-07
- 2021-05-08
- 2021-05-09
- 2021-05-16
- 2021-05-23
- 2021-05-30
- 2021-06-06
- 2021-06-13
- 2021-08-01
- 2021-10-31
-
2021-12-09
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-12-12
- 2021-12-13
- 2021-12-14
- 2021-12-15
- 2021-12-16
- 2021-12-23
- 2021-12-30
- 2022-01-06
- 2022-01-13
- 2022-01-20
- 2022-03-10
- 2022-06-09
-
2022-09-24
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-25
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness · HeadacheAdult check-in
-
2022-09-26
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-09-27
- 2022-09-29
- 2022-10-03
- 2022-10-09
-
2022-10-17
Survey response — day 21, dose 4MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: FairFree text: Runny nose, sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-10-22
- 2022-10-29
- 2022-11-05
- 2022-12-26
- 2023-03-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-11 | Pfizer-BioNTech | |
| 2 | 2021-05-02 | Pfizer-BioNTech | |
| 3 | 2021-12-09 | Pfizer-BioNTech | Flu |
| 4 | 2022-09-24 | Pfizer-BioNTech | Flu |
Free text
Release 12 — day 21, dose 4
Symptoms: Runny nose, sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release